Breast Cancer Metabolism and Mitochondrial Activity: The Possibility of Chemoprevention with Metformin.

作者: Massimiliano Cazzaniga , Bernardo Bonanni

DOI: 10.1155/2015/972193

关键词:

摘要: Metabolic reprogramming refers to the ability of cancer cells alter their metabolism in order support increased energy request due continuous growth, rapid proliferation, and other characteristics typical neoplastic cells. It has long been believed that increase metabolic was independent mitochondrial action but recently we know activity together with plays a pivotal role regulation needed for tumor cell growth proliferation. For these reasons mitochondria pathways could be new target therapeutic chemopreventive intervention. Metformin particular is actually considered promising agent against thanks its inhibit complex I.

参考文章(85)
Francis M. Giardiello, Jill D. Brensinger, Anne C. Tersmette, Steven N. Goodman, Gloria M. Petersen, Susan V. Booker, Marcia Cruz–Correa, Johan A. Offerhaus, Very High Risk of Cancer in Familial Peutz—Jeghers Syndrome Gastroenterology. ,vol. 119, pp. 1447- 1453 ,(2000) , 10.1053/GAST.2000.20228
William W Wheaton, Samuel E Weinberg, Robert B Hamanaka, Saul Soberanes, Lucas B Sullivan, Elena Anso, Andrea Glasauer, Eric Dufour, Gokhan M Mutlu, GR Scott Budigner, Navdeep S Chandel, Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis eLife. ,vol. 3, ,(2014) , 10.7554/ELIFE.02242
Álvaro D. Ortega, María Sánchez-Aragó, Daniel Giner-Sánchez, Laura Sánchez-Cenizo, Imke Willers, José M. Cuezva, Glucose avidity of carcinomas Cancer Letters. ,vol. 276, pp. 125- 135 ,(2009) , 10.1016/J.CANLET.2008.08.007
R A Gatenby, K Smallbone, P K Maini, F Rose, J Averill, R B Nagle, L Worrall, R J Gillies, Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer British Journal of Cancer. ,vol. 97, pp. 646- 653 ,(2007) , 10.1038/SJ.BJC.6603922
Antonio F. Santidrian, Akemi Matsuno-Yagi, Melissa Ritland, Byoung B. Seo, Sarah E. LeBoeuf, Laurie J. Gay, Takao Yagi, Brunhilde Felding-Habermann, Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression Journal of Clinical Investigation. ,vol. 123, pp. 1068- 1081 ,(2013) , 10.1172/JCI64264
Mathieu Laplante, David M. Sabatini, mTOR signaling in growth control and disease. Cell. ,vol. 149, pp. 274- 293 ,(2012) , 10.1016/J.CELL.2012.03.017
Stephanos Pavlides, Diana Whitaker-Menezes, Remedios Castello-Cros, Neal Flomenberg, Agnieszka K. Witkiewicz, Philippe G. Frank, Mathew C. Casimiro, Chenguang Wang, Paolo Fortina, Sankar Addya, Richard G. Pestell, Ubaldo E. Martinez-Outschoorn, Federica Sotgia, Michael P. Lisanti, The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma Cell Cycle. ,vol. 8, pp. 3984- 4001 ,(2009) , 10.4161/CC.8.23.10238
Matthew G. Vander Heiden, Targeting cancer metabolism: a therapeutic window opens Nature Reviews Drug Discovery. ,vol. 10, pp. 671- 684 ,(2011) , 10.1038/NRD3504
Ryan JO Dowling, Saroj Niraula, Martin C Chang, Susan J Done, Marguerite Ennis, David R McCready, Wey L Leong, Jaime M Escallon, Michael Reedijk, Pamela J Goodwin, Vuk Stambolic, Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study Breast Cancer Research. ,vol. 17, pp. 32- 32 ,(2015) , 10.1186/S13058-015-0540-0
P.J. Pollard, J.J. Brière, N.A. Alam, J. Barwell, E. Barclay, N.C. Wortham, T. Hunt, M. Mitchell, S. Olpin, S.J. Moat, I.P. Hargreaves, S.J. Heales, Y.L. Chung, J.R. Griffiths, A. Dalgleish, J.A. McGrath, M.J. Gleeson, S.V. Hodgson, R. Poulsom, P. Rustin, I.P.M. Tomlinson, Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Human Molecular Genetics. ,vol. 14, pp. 2231- 2239 ,(2005) , 10.1093/HMG/DDI227